Sofis Partners with Arcadea Group
Arcadea Group has announced the acquisition of Sofis, a leading provider of mission-critical software for the Brazilian healthcare sector, specializing in hemotherapy and cell therapy. Sofis, founded in 1986 in Rio de Janeiro, offers products such as Hemote Plus for blood bank and transfusion services management, Cellvida for cell therapy, and Salute for hospital management.
TORONTO & RIO DE JANEIRO–(BUSINESS WIRE)–Arcadea Group, a preeminent, long-term investor in global software businesses, today announced the acquisition of Sofis, a leading providing of mission-critical software to the Brazilian healthcare sector, focused on hemotherapy and cell therapy. Founded in Rio de Janeiro in 1986 by Reynaldo Mendes, Sofis’ product portfolio includes Hemote Plus for blood bank and transfusion services management, Cellvida for cell therapy, Salute for hospital management